Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Mosunetuzumab High Grade B-Cell Lymphoma	OHSU Knight Cancer Institute	P2	B (60)
Muamycin Metastatic Neoplasm	City of Hope Medical Center	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Carcinosarcoma	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Serous Adenocarcinoma	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Cancer	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Seromucinous Carcinoma	Mayo Clinic	P2	B (60)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Hematopoietic And Lymphoid Cell Neoplasm	City of Hope Medical Center	P2	B (60)
Muzastotug Colorectal Cancer	City of Hope Medical Center	P2	B (60)
Nab-Sirolimus Neoplasm	Aadi Bioscience, Inc.	P2	B (60)
Naproxen Lynch Syndrome	M.D. Anderson Cancer Center	P2	B (60)
Nerofe Myelodysplastic Syndrome	Immune System Key Ltd	P2	B (60)
Niclosamide Metastatic Prostate Carcinoma	University of California, Davis	P2	B (60)
Niclosamide Prostate Carcinoma	University of California, Davis	P2	B (60)
Niclosamide Prostate Cancer	University of California, Davis	P2	B (60)
Niraparib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	B (60)
Niraparib Prostate Adenocarcinoma	Mayo Clinic	P2	B (60)
Nivolumab Prostate Adenocarcinoma	Emory University	P2	B (60)
Nivolumab Adrenal Cortex Carcinoma	Dana-Farber Cancer Institute	P2	B (60)
Nivolumab Head And Neck Carcinoma	National Cancer Institute (NCI)	P2	B (60)
Nivolumab Non-Small Cell Squamous Lung Carcinoma	Brigham and Women's Hospital	P2	B (60)
Nivolumab Disease Related To Hematopoietic Stem Cell Transplant	St. Petersburg State Pavlov Medical University	P2	B (60)
Nivolumab Astrocytoma, IDH-Mutant, Grade 4	Andrew P. Groves	P2	B (60)
Nivolumab B-Cell Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	B (60)
Nivolumab Urinary Bladder Small Cell Neuroendocrine Carcinoma	National Cancer Institute (NCI)	P2	B (60)

Showing 1951 to 1975 of 13,155 assets

PreviousPage 79 of 527Next